· web viewhelicobacter pylori induces the early growth response-1 gene in gastric epithelial...

Curriculum Vitae Mohamed M.M. Abdel-Latif, Ph.D.---------------------------------------------------------------------------------------------------------------------------

CURRICULUM VITAEDr. Mohamed Mahmoud Mohamed Abdel-Latif

1. PERSONAL DATAName: Mohamed Mahmoud Mohamed Abdel-LatifDate of Birth: 19/02/1968Sex: MalePlace of Birth: EgyptNationality: EgyptContact Address: Address: Department of Clinical Pharmacy, Faculty of Pharmacy, Assiut University, Assiut, Egypt.Tel (Mobile): 00201010607375Tel (work): 00208820801347 Fax: 0020882080774Email: [email protected] / [email protected]

2. ACADEMIC QUALIFICATIONS1- B.Sc., Pharmaceutical Sciences with 1st Class Honours (1991), Assiut

University, Faculty of Pharmacy, Assiut, Egypt.2- M.Sc., Pharmaceutical Sciences (1997), Assiut University, Faculty of

Pharmacy, Assiut, Egypt. 3- Ph.D., Clinical Pharmacy (2003), University of Dublin, Trinity College

Dublin, Ireland.

3. OCCUPATION DETAILS

Demonstrator(13/4/1992-7/6/1997)

Pharmaceutics Department, Faculty of Pharmacy, Assiut University, Assiut, Egypt

Assistant Lecturer(8/6/1997-2/8/2003)


Ph.D. Researcher

(23/4/1998-2/8/2003)

Ph.D Scholarship, University of Dublin, Trinity College Dublin, Dublin, Ireland

Lecturer(3/8/2003-22/9/2008)


Research Fellow(29/4/2004-28/7/2006)

Department of Clinical Surgery, Trinity College Dublin, Ireland

Associate Professor(23/9/2008-27/3/2010)


Research Fellow Department of Clinical Medicine, Trinity

1


(1/9/2008-31/3/2010) College Dublin, IrelandScientific advisor of Registration of Pharmaceuticals(1/4/2010-31/8/2011)

Central Administration for Pharmaceutical Affairs, Ministry of Health, Egypt

Associate Professor(28-3-2010-Present)

Clinical Pharmacy Department, Faculty of Pharmacy, Assiut University, Assiut, Egypt

Associate Professor(1/9/2011-3/8/2016)

Clinical and Hospital Pharmacy Department, Faculty of Pharmacy, Taibah University, Al-Madinah Al-Munwwarah, KSA

Department Coordinator(2012-2013)

Clinical and Hospital Pharmacy Department, College of Pharmacy, Taibah University, Al-Madinah Al-Munwwarah, KSA

Acting Head of Department(28/9/2016-13/12/2017)


Professor(28/11/2017)


Head of Department(14/12/2017-Present)


4. PROFESSIONAL AND ADMINSTRATIVE POSITIONS1- Scientific advisor of registration of pharmaceuticals, Central Administration for

Pharmaceutical Affairs (CAPA), Ministry of Health, Egypt (1/1/2010-31/8/2011).

2- Head of Department, Clinical and Hospital Pharmacy Department, Faculty of Pharmacy, Taibah University, Al-Madinah Al-Munwwarah, KSA (2012-2013).

3- Head of Department, Clinical Pharmacy Department, Faculty of Pharmacy, Assiut University, Egypt (28-9-2016-Present).

5. MEMERSHIP OF PROFESSIONAL BODIES AND COMMITTEES1- Egyptian Pharmaceutical Society (1991). 2- General Syndicate of Pharmacists (1991).3- Member of the Quality Assurance Unit, Faculty of Pharmacy, Assiut

University, Assiut, Egypt (2004).4- Continuous Improvement and Qualifying for Accreditation Project (CIQAP)

project, Faculty of Pharmacy, Assiut University, Assiut, Egypt (2008).5- Committee for drug approval at Central Administration for Pharmaceutical

Affairs, CAPA (1/1/2010 -31-8-2011).6- Scientific Council for Clinical Pharmacy Fellowship, High Committee of

Medical Specialties (23/5/2010-31-8-2011).

2


7- Faculty of Pharmacy council (2016).8- Committee of Faculty of Pharmacy for Clinical Pharmacy Program (2016).9- Higher committee of Assiut University for Clinical Pharmacy Program (2016).

6. JOURNAL EDITORIAL BOARD MEMBERSHIP AND SERVICES

a. Journal Editorial Board 1- Editorial board member of Anticancer Drugs.2- Editorial board member of World Journal of Pharmacology.3- Editorial board member of Medicine.4- Editorial board member of Journal of Surgery Research and Practice.5- Editorial board member of Journal of Health Education.6- Editorial board member of Journal of Applied Pharmacy.7- Editorial board member of Bioequivalence & Bioavailability International

Journal (BEBA).8- Editorial board member of Journal of Health Science and Education.

b. Reviewer for Scientific Journals 1- Anticancer Drugs2- GUT3- American Journal of Gastrointestinal and Liver Physiology 4- Cancer Immunology and Immunotherapy5- Yonsei Medical Journal6- Cellular Microbiology7- Life Sciences8- Pharmacological Research9- International Journal of Cell Biology10- BioMed Central Infectious Diseases11- BioMed Central Microbiology12- International Journal of Biochemistry and Cell Biology 13- Journal of Ethanopharmacology14- World Journal of Gastroenterology15- Surgery Research Practice16- Medicine

4. TEACHING EXPERIENCESa) Undergraduate courses:

Teaching a variety of pharmacy practice and clinical pharmacy courses for pharmacy students, mentoring, examining and evaluating students.

b) Postgraduate coursesTeaching a variety of clinical pharmacy courses, molecular biology and molecular medicinesubjects for postgraduate students.

3


Recent trends in drug delivery systems course for Ph.D students, Assiut University, Assiut, Egypt at Faculty of Pharmacy, Assiut University, Assiut, Egypt and University of Dublin, Ireland.

c) Field traininga. Training and supervision of pharmacy students in In-patient and Out-

patient field training in hospital settings.b. Training and supervision of pharmacy students in community pharmacy

field training.

5. RESEARCH EXPERIENCESa. Research Interests

1- Clinical and hospital pharmacy services2- Drug use evaluation3- Health education and health promotion.4- Oncology (Cancer epidemiology, carcinogenesis and gene regulation of

gastrointestinal cancers).5- Chemotherapy and chemoprevention.6- Helicobacter pylori: infection, molecular mechanisms and treatment.

b. Research Grants1- Successful applicant in applying for funding for supplementation of vitamin

for Barrett's oesophagus and oesophageal cancer from Irish Society of Cancer 2003 (250.000 Euros over 3-years).

2- Successful applicant in applying for funding for development and implementation of clinical pharmacy courses for pharmacy students project from HEEPF, Egypt, 2004 (100.000 Dollars over 2 years).

3- Participant in applying for quality assurance and accreditation project for Faculty of Pharmacy, Assiut University, Assiut, Egypt (2004).

4- Participant in applying for continuous improvement and qualifying for accreditation project (CIQAP) for Faculty of Pharmacy, Assiut University, Assiut, Egypt (2008).

c. Laboratory Experiences1- Strong base in drug formulation and evaluation.2- Clinical pharmacy services (qualitative and quantitative studies).3- Experience in molecular and cellular approach in testing new chemical

entities and drug effects.4- Strong background in a broad range of molecular and biochemical

techniques (protein extraction, Western blotting, plasmid purification and transformation, DNA extraction, transfection and reporter assays, ELISA technique, immunofluorescence, gel electrophoresis and confocal microscopy).

5- High content screening assays for screening drug activities6- Cell culture, cell extraction, collection and processing of tumour and normal

patients specimens and blood samples.

4


6. FACULTY AND LEADERSHIP DEVELOPMENT TRAINING COURSES (FLDC)1- Training course on "Management of scientific research", Faculty and

leadership development center, Assiut University, Assiut, Egypt, December 2006.

2- Training course on "Teaching evaluation", Faculty and leadership development center, Assiut University, Assiut, Egypt, July 7th-9th, 2007.

3- Training course on "Legal aspects in univeristies", Faculty and leadership development center, Assiut University, Assiut, Egypt, July 7th-9th, 2007.

4- Training course on "Preparing, writing and international publishing of research papers", Faculty and leadership development center, Assiut University, Assiut, Egypt, October 20th-22nd, 2007.

5- Training course on "Credit hours system", Faculty and leadership development center, Assiut University, Assiut, Egypt, October 20th-22nd, 2007.

6- Training course on "Use of technology in teaching", Faculty and leadership development center, Assiut University, Assiut, Egypt, October 27th-29th, 2007.

7- Training course on "Writing a competitive research project", Faculty and leadership development center, Assiut University, Assiut, Egypt, October 27th-29th, 2007.

8- Training course on "Design of an electronic course", Faculty and leadership development center, Assiut University, Assiut, Egypt, October 30th-31st, 2016.

9- Training course on "Accreditation standards in teaching system 1", Faculty and leadership development center, Assiut University, Assiut, Egypt, October 16th-17nd, 2016.

10- Training course on "Run an electronic course", Faculty and leadership development center, Assiut University, Assiut, Egypt, November 15th-16th,, 2016.

11- Training course on "Statistics in scientific research", Faculty and leadership development center, Assiut University, Assiut, Egypt, October 25th-26th, 2016.

12- Training course on "Design and run of scientific research", Faculty and leadership development center, Assiut University, Assiut, Egypt, October 25th-26th, 2016.

13- Training course on "Strategic planning", Faculty and leadership development center, Assiut University, Assiut, Egypt, November 27th-28th, 2016.

7. TRAINING COURSES AND WORKSHOPS1- Workshop on "Radiological Protection", 13th-14th December 2004, Dublin,

Ireland.2- Training course on" preparing research plan for accreditation and quality

assurance", 2006, Cairo University, Cairo, Egypt.3- Meeting of "Role of university leaders in enhancing accreditation and quality

assurance systems" on 30th October 2007, Assiut University, Assiut, Egypt.4- Workshop on "Design of faculty plan for accreditation" on 20th June 2007,

Commerce faculty, Cairo University, Cairo, Egypt.

5


5- Training course on "writing international research project", 2008, British Centre, Assiut Universiy, Assiut.

6- Training programme on "Good governance for medicines" on 13th-15th December 2010, World Health Organization (WHO) Regional Office, Cairo, Egypt.

7- Training programme on "Good governance for medicines" on 25th-27th July 2011, World Health Organization (WHO) Regional Office, Cairo, Egypt.

8- Training program of Ministry of Health of Egypt with Harvard University on "Management training program for health leaders" on 8th January till 13 January 2011, National training Institute, Cairo, Egypt.

9- Scientific activity on "Drugs and Cardiology" on 5th June 2012, Dar Al-Iman Intercontinental Hotel, Al-Madinah Al-Munawwarh, Saudi Arabia.

10- Training program on "Management of disagreement in academic departments" on 29th of April 2014, Taibah University, Al-Madniah Al-Munwwarah, Saudi Arabia.

11- Training program on "Academic advising" on 12th February 2014, Taibah University, Al-Madniah Al-Munwwarah, Saudi Arabia.

12- Training program on "Psychological advising" on 27th February 2014, Taibah University, Al-Madniah Al-Munwwarah, Saudi Arabia.

13- Training program on "Excel-first level" on 20th February 2014, Taibah University, Al-Madniah Al-Munwwarah, Saudi Arabia.

14- Training program on "Excel-advanced level" on 24th February 2014, Taibah University, Al-Madniah Al-Munwwarah, Saudi Arabia.

15- Training program on "Powerpoint-advanced level" on 16th February 2014, Taibah University, Al-Madniah Al-Munwwarah, Saudi Arabia.

16- Training program on "SPSS" on 19th February, 2014, Taibah University, Al-Madniah Al-Munwwarah, Saudi Arabia.

17- Training program on "Skills of decisions-making and solving problems" on 23rd of November 2015, Taibah University, Al-Madniah Al-Munwwarah, Saudi Arabia.

18- Training program on "Time management skills" on 7th December 2015, Taibah University, Al-Madniah Al-Munwwarah, Saudi Arabia.

19- Workshop on “Registration in Egyptian Knowledge Bank and navigation of different information resources from scientific publishers. On 7th of March 2018, Faculty of Pharmacy, Assiut University, Assiut, Egypt.

20- 5th workshop of Pediatric Clinical Nutrition Unit on “Guidelines for Intravenous Fluid Therapy and Total Parenteral Nutrition”, on 22th of March 2018, Assiut University Children Hospital, Assiut, Egypt.

8 .AWARDS AND HONOURS1- Gold Medal from Faculty of Pharmacy, Assiut University, Egypt in

recognition as the 1st Class Honours (1992).2- Gold Medal from Egyptian Syndicate of Pharmacists in recognition as the 1st

Class Honours (1993).3- Egyptian Ph.D. Scholarship (1998) funded by Egyptian Government.4- 1st Poster Best Award from the Irish Society of Immunology Meeting (2001),

Dublin, Ireland (Won a Gold Medal and 200 Irish Pound).

6


5- 2nd Oral Best Presentation from the Irish Society of Gastroenterology Meeting (2002), Cork, Ireland (Won 750 Irish Pound).

6- Poster of Distinction. Nuclear Factor-kappa B: Relationship to Barrett’s adenocarcinoma, stage and response to neoadjuvant chemotherapy treatment. Digestive Disease Week, May 21-24, 2002, New Orleans, LA.

7- Travel grant from the UEGW to attend the Annual Meeting of the United European Gastroenterology Week (UEGW), Geneva, Switzerland 2003 (One of the best 200 abstracts and won 1000 Euros).

8- Travel grant from the UEGW to attend the Annual Meeting of the UEGW, Copenhagen, Denmark 2005 (One of the best 200 abstracts and won 1000 Euros).

9- Travel grant from the UEGW to attend the Annual Meeting of the UEGW, Berlin, Germany 2006 (One of the best 200 abstracts and won 1000 Euros).

9. SERVICES TO UNIVERSITY AND PROFESSION1- Development and implementation of clinical pharmacy courses for pharmacy

students, Faculty of Pharmacy, Assiut University (2004).2- Educational workshop for Hospital pharmacists, Faculty of Pharmacy, Assiut

University, Assiut, Egypt (2008).3- Continuous pharmaceutical education for hospital pharmacists. Egyptian Drug

Authority, Ministry of Health (2010).

10. SERVICES TO FACULTY1- Member of a number of committees of faculty of pharmacy, Assiut,

university, Assiut, Egypt.2- Member of faculty committee of International Pharmaceutical Conference of

Assiut University 2004 and 2008.3- Moderator of scientific society for pharmacy students.4- Supervisor of and participant in social activities.

11. LANGUAGE PROFICIENCY1- Arabic (Native language).2- English (Written and Spoken).

12. LEISURE AND PERSONAL INTEREST S Outdoors sports, football, camping, documentary films, reading and travel, history.

13. CONFERENCES AND PRESENTATIONS1- Abdel-Latif M. M. Hospital Pharmacy Services. Oral Presentation. First

Annual Scientific Conference of Assiut University Hospital Pharmacists 2018, 17-18 April, Assiut, Egypt.

2- Abdel-Latif M. M. Role of the Clinical Pharmacist in Nutrition in Cancer. Oral Presentation. Ninth Annual International Conference of Clinical

Oncology Department Asiut University, 2018, 21-23 February, Assiut, Egypt.

7


3- Abdel-Latif M. M., Hassan S.B. Knowledge, attitude and of self-medication among Egyptian subjects. Poster Presentation. Eleventh Pharmaceutical Assiut University Conference 2018, 11-12 April, Assiut, Egypt.

4- Abdel Aal N.H., Mahmoud R.S., Abdel-Latif M. M., Mohamed R.M., Hassan S.B. Clinical and economic impact of clinical pharmacy services at Assiut University Children Hospital: A Retrospective preliminary study. Poster Presentation. Eleventh Pharmaceutical Assiut University Conference 2018, 12-12 April, Assiut, Egypt.

5- Abdel-Latif M. M. Role of the clinical pharmacist in hospital settings. Oral Presentation. First Scientific Day of Clinical Pharmacy Unit, on 19th April 2017, Urology and Nephrology Science Hospital Assiut, Egypt.

6- Abdel-Latif M. M. Recent trends in pharmaceutical sciences symposium, 13th-14th April 2013, Le-Meridien Madinah, Al-Madinah Al Munwwarrah, Saudi Arabia.

7- Abdel-Latif M. M. Clinical Pharmacy: Past, Present and Future. 26 April 2011, Faculty of Pharmacy, Assiut University Conference, Assiut, Egypt.

8- Abdel-Latif M. M. Drug manufacturing in Egypt: Present, future and challenges. 21st December, 2010. Conference Centre, Cairo University, Cairo, Egypt.

9- Abdel-Latif M. M. Drug registration: Local updates. USP and Middle East/North Africa (MENA) Stakeholders 4th Science & Standards Symposium Exploring the Latest Advances & Trends in Standards & Regulations. 12th-13th

October, 2010, Semiramis Intercontinental Cairo Hotel, Cairo, Egypt10- Abdel-Latif M. M. Dubai International Pharmaceuticals and Technologies

conference and Exhibition on 15th-17th March 2010, Dubai, United Arab Emirates.

11- Abdel-Latif M. M. Registration System of Pharmaceutical Products in Egypt. Arab League Meeting 21-23 February 2010, Sharm El-Sheikh, Egypt.

12- Abdel-Latif M. M., Shane Duggan, Hiroyoshi Inoue, Dermot Kelleher, John V. Reynolds. Suppressive Effects of Ursodeoxycholic Acid on Deoxycholic Acid-Induced Activation of Signal Transduction Pathways in Oesophageal Cancer Cells. Poster Presentation. ISG Annual Meeting, 19-20th November 2009, TRIM, Dublin, Ireland.

13- Abdel-Latif M. M., Ravi N., Kelleher D., Reynolds J. V. Molecular mechanisms of constitutive activation of nuclear factor-kappa B in oesophageal adenocarcinoma. 12th Annual Meeting of the Institute of Molecular Medicine. 13-14 November 2009, Dublin, Ireland

14- Abdel-Latif M. M., Shane Duggan, Hiroyoshi Inoue, Dermot Kelleher, John V. Reynolds. Suppressive Effects of Ursodeoxycholic Acid on Deoxycholic Acid-Induced Activation of Signal Transduction Pathways in Oesophageal Cancer Cells. Poster Presentation. IMM 12th Annual Meeting, 13-14th

November 2009, Dublin, Ireland.15- Abdel-Latif M. M., Kelleher D., Reynolds J. V. Molecular targeting of

transcription factors in oesophageal adenocarcinoma as an avenue for cancer therapy. Oral Presentation. Sixth Pharmaceutical Assiut University Conference 2008, 12-13 March, Assiut, Egypt.

16- Abdel-Latif M. M., Kelleher D., Reynolds J. V. Targeting of nuclear transcription factor NF-B in oesophageal cancer. Poster Presentation.

8


Thirtieth Pharmaceutical Sciences conference 2006, 19-21 December, Cairo, Egypt.

17- Abdel-Latif M. M., Volkov Y., Windle H. J., Davies A., Williams Y., Reynolds J. V., Kelleher D. Acid induces early growth response-1 transcription factor in gastric epithelial cells. Poster Presentation. UEGW 2006, 20-25 October, Berlin, Germany.

18- Abdel-Latif M. M., Kelleher D., Reynolds J. V. Molecular mechanisms of constitutive activation of nuclear factor-kappa B in oesophageal adenocarcinoma. Oral Presentation. UEGW 2006, 20-25 October, Berlin, Germany.

19- Miriam Byrne, Mohamed M. Abdel-Latif, Reynolds JV. Lymphoctye NF-B activation. OESO 2006, 3-6 September, Paris, France.

20- Mohamed M. M. Abdel-Latif, Dermot Kelleher and John V. Reynolds. Administration of Vitamin C in Combination with Chemotherapeutic Agents Enhances Chemosensitization in Oesophageal Cancer Cells In Vitro. Oral Presentation. UEGW 2005, 15-19 October, Copenhagen, Denmark.

21- Mohamed M. M. Abdel-Latif, Jamie M. O’Riordan, Ravi Narayanasamy, Dermot Kelleher, John V. Reynolds. NF-kappaB Activity and Cytokines Pattern Pre and Post Chemoradiotherapy in Oesophageal Cancer Patients. UEGW 2005, 15-19 October, Copenhagen, Denmark.

22- Mohamed M. M. Abdel-Latif, Jamie M. O’Riordan, Ravi Narayanasamy, Dermot Kelleher, John V. Reynolds. NF-kappaB Activity and Cytokines Pattern Pre and Post Chemoradiotherapy in Oesophageal Cancer Patients. Association of Surgeons of Great Britain and Ireland, Scotland, UK 13-16 April 2005 (Br J Surg, ASGBI Abstracts 2005;92:56-63).

23- Mohamed M. M. Abdel-Latif, Jamie M. O’Riordan, Ravi Narayanasamy, Dermot Kelleher, John V. Reynolds. NF-kappaB Activity and Cytokines Pattern Pre and Post Chemoradiotherapy in Oesophageal Cancer Patients. AUGIS, Dublin, Ireland 22-23 September 2005 (Br J Surg, ASGBI Abstracts 2005;92:56-63).

24- Mohamed M. M. Abdel-Latif, Dermot Kelleher and John V. Reynolds. Administration of Vitamin C in Combination with Chemotherapeutic Agents Enhances Chemosensitization in Oesophageal Cancer Cells In Vitro. Irish Society of Gastroenterology, Dublin, Ireland 26-27 November 2004.

25- Duggan S., Abdel-latif M., Fox E, Gallagher W., Reynolds J. V., Kelleher D. Low pH Results in Co-ordinate Regulation of Gene Expression in Esophageal Cells. DDW, May 15-20, 2004, New Orleans, LA. S1694.

26- Mohamed M. M. Abdel-Latif, Dermot Kelleher John V. Reynolds. 5-Fluorouracil and Cisplatin Induce NF-B, AP-1 and COX-2 Transcription in Oesophageal Epithelial Cells: A role for PKC and MAPK Signalling Pathways Involvement. DDW, May 17-22, 2003, Orlando, FL.

27- Mohamed M. M. Abdel-Latif, Dermot Kelleher John V. Reynolds. Helicobacter pylori Water Extract Induces Nuclear Factor-kappa B, Activator Protein-1 and Cyclooxygenase-2 in Oesophageal Epithelial Cells: Evidence for role of p38, ERK and JNK phosphorylation. DDW, May 17-22, 2003, Orlando, FL.

28- James O’Riordan, Mohamed M. M. Abdel-Latif, Debby McNamara, Ravi Narayanasamy, Patrick Byrne, Paul W. Keeling, Dermot Kelleher. John V. Reynolds. Nuclear Factor-kappa B Induced Cytokine Expression Along the

9

http://www3.interscience.wiley.com/cgi-bin/jissue/110436182

http://www3.interscience.wiley.com/cgi-bin/jissue/110436182

http://www3.interscience.wiley.com/cgi-bin/jhome/99019821

http://www3.interscience.wiley.com/cgi-bin/jhome/99019821


Metaplasia-Dysplasia-Adenocarcinoma Sequence in the Esophagus. DDW, May 17-22, 2003, Orlando, FL.

29- Eileen Looby, Mohamed M. M. Abdel-Latif, Veronica Athie Morales, Dermot Kelleher. Bile Acid Exposure Induces Activation of the Extracellular Signal-Regulated Kinase and the Transcription Factor AP-1 in Esophageal Cancer Cells. DDW, May 17-22, 2003, Orlando, FL.

30- Syed A. Shah, Eileen Looby, Mohamed M. M. Abdel-Latif, Yuri Volkov, Aideen Long, Dermot Kelleher. Differential Effects of Tumour Promoting Bile Acid Deoxycholic Acid and Chemoprotective Ursodeoxycholic Acid on Protein Kinase C beta, epsilon, and transcription factors, NF-kappaB and AP-1 in Human Colon Cancer Cells. DDW, May 17-22, 2003, Orlando, FL.

31- J. M. O'Riordan, M. M. Abdel-Latif, D. McNamara, N. Ravi, D. Kelleher, P. W. N. Keeling and J. V. Reynolds. Cytokine and NF- B profiles in the metaplasia-dysplasia-adenocarcinoma sequence in the oesophagus.(Br J Surg, SARS Abstract 2003:598-638).

32- Mohamed M. Abdel-Latif, H. Windle, E. Carton, D. Kelleher, J. V. Reynolds. Nuclear Factor-kappa B: Relationship to Barrett’s adenocarcinoma, stage and treatment response. Br J Sur 2002; 89:646-647.

33- Mohamed M. Abdel-Latif, J. M. O’Riordan, H. Windle, D. Kelleher, J. Reynolds. Nuclear Factor-kappa B: Relationship to Barrett’s adenocarcinoma, stage and response to neoadjuvant chemotherapy treatment. United European Gastroenterology Week (UEGW), Geneva, Switzerland 2003 (Gut 2002; 51 (Supp III): A83. Poster presentation).

34- Mohamed M. Abdel-Latif, El-Homasany BS, Windle JH, Kelleher D and Sabra K.Inhibitory Effects of Natural Honey on Helicobacter Pylori: A role for nuclear factor- Kappa B. Activator Protein-1 and COX-2 Transcription Factors (Ireland). ASHP Midyear Clinical Meeting 2002 INTL-71.

35- Mohamed M. Abdel-Latif, J. M. O’Riordan, H. Windle, D. Kelleher, J. Reynolds. Nuclear Factor-kappa B: Relationship to Barrett’s adenocarcinoma, stage and response to neoadjuvant chemotherapy treatment. Irish Society of Gastroenterology, Cork, Ireland 2001.

36- Mohamed M. Abdel-Latif, Henry J. Windle, Yeng S. Ang, Deirdre Nì Eidhin, Kamal Sabra, Dermot Kelleher Induction of the Early Growth Response-1 Transcription Factor in Gastric Epithelial Cells by Helicobacter pylori. Digestive Disease Week (DDW), San Diego, California, USA, 2000: p-678.

37- Mohamed M. Abdel-Latif, MJ Windle, D. NiEdhin, K. Sabra and D. Kelleher Helicobacter Pylori Induces the Early Growth Response-1 Gene W. Gastric Epithelial Cells (Ireland). ASHP, (INTL-21) Dec 1999.

38- Mohamed M. Abdel-Latif, H. J. Windle, D. Nì Eidhin, K. Sabra, D. Kelleher. Helicobacter pylori Induces the Early Growth Response-1 Gene in Gastric Epithelial Cells. Irish Society of Gastroenterology, Dublin (Ir J M Sci 1999; 168 (Supp 5): p-15).

39- Mohamed M. Abdel-Latif, H. J. Windle, D. Nì Eidhin, K. Sabra, D. Kelleher. Effects of Antioxidants on NF-kappa B Activation by Helicobacter pylori in Gastric Epithelial Cells. Irish Society of Gastroenterology, Dublin (Ir J M Sci 1999; 168 (Supp 9): p-27).

10


40- Mohamed M. Abdel-Latif, H. J. Windle, D. Nì Eidhin, K. Sabra, D. Kelleher. Helicobacter pylori Induces the Early Growth Response-1 Gene in Gastric Epithelial Cells. Irish Society of Immunology (ISC) Dublin 1999.

41- E. S. Ibrahim, A. K. Al-Hussani, A.A. El-Shanawany, Mohamed M. Abdel-Latif, S. Al-Ghalibi, T. A. Ali. 136th British Pharmaceutical Conference, Cardiff, UK: Journal of Pharmacy and Pharmacology 1999; 51 (Supp l): p-194. p-194.

42- S. A. Ibrahim, S. S. Tous, A. K. Al-Hussani, A. A. El-Shanawany, E. A. Daef, A. S. Aly, Mohamed M Abdel-Latif. 16th Pharmaceutical Technology Conference, Athens, Greece, March (1997).

15. PEER-REVIWED PUBLICATIONS 1- Abdel-Latif MM, Babar M, Kelleher D, Reynolds JV. A pilot study of the

impact of vitamin C supplementation with neoadjuvant chemoradiation on regulators of inflammation and carcinogenesis in esophageal cancer patients. Journal of Cancer Research and Therapeutics, 2018 (DOI: 10.4103/jcrt.JCRT_763_16).

2- Abdel-Latif MMM, Saad SY. Health literacy among Saudi population: a cross-sectional study. Health Promot Int. 2017 Sep 12. doi: 10.1093/heapro/dax04.

3- El-Kholy AA, Abdel-Latif MMM. Publics' perceptions of community pharmacists and satisfaction with pharmacy services. European Journal of Pharmaceutical and Medical Research. 2017;4(9):165-176.

4- Abdel-Latif M.M.M. Hospital doctors' views of, collaborations with and expectations of clinical pharmacists. European journal of Hospital Pharmacy: Science and Practice. 2016;0:1–6. doi:10.1136/ejhpharm-2016-001075.

5- Abdel-Latif M.M., Abouzied M.M. Molecular Mechanisms of Natural Honey Against H. pylori Infection Via Suppression of NF-κB and AP-1 Activation in Gastric Epithelial Cells. Archives of Medical Research. 2016;47(5):340-348.

6- Abdel-Latif M.M. Knowledge of healthcare professionals about medication errors in hospitals. Journal of Basic and Clinical Pharmacy. 2016;7(3):87-92.

7- Abdel-Latif M.M.M., Sabra K. Clinical Pharmacy Practice in Egypt: Hospital perspective. American Journal of Health-System Pharmacy. 2016;73(1):e63-66.

8- Saad S.Y., Abdel-Latif M.M. Association between Obesity and Coronary Heart Disease Risk among Saudi Subjects at Madinah Region. British Journal of Pharmaceutical Research. 2016;12(3):1-8.

9- Abdel-Latif M.M.M., Inoue H., Reynolds JV. Opposing effects of bile acids deoxycholic acid and ursodeoxycholic acid on signal transduction pathways in oesophageal cancer cells. European Journal of Cancer Prevention. 2016;25(5):368-379.

10- Ibrahim S. R. M., Mohamed G. A., Abdel-Latif M.M.M., El-Messery S. M., Al Musayeib N. M., Shehata I. A. Minutaside A, new α-amylase inhibitor flavonol glucoside from Tagetes minuta: Antidiabetic, antioxidant, and molecular modeling studies. Starch/Stärke. 2015; 67(11-12):976–984.

11


11- Abdel-Latif M.M., Inoue H., Kelleher D., Reynolds J.V. Factors regulating nuclear factor-kappa B activation in esophageal cancer cells: Role of bile acids and acid. Journal of Cancer Research and Therapeutics. 2016;12(1):364-367.

12- Abdel-Latif M.M.M. Chemoprevention of gastrointestinal cancers by natural honey. World Journal Pharmacology. 2015;4:160-167.

13- Abdel-Latif M.M.M., Abdel-Wahab B.A. Knowledge and Awareness of Adverse Drug Reactions and Pharmacovigilance Practices among Healthcare Professionals in Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia. Saudi. Pharmaceutical Journal. 2015;23:154-161.

14- Abdel-Latif M.M.M., Kelleher K., Reynolds J. V. Molecular mechanisms of constitutive and inducible NF-kappaB activation in oesophageal adenocarcinoma . European Journal of Cancer. 2015;51:464-472.

15- Ibrahim S.R.M., Mohamed G.A., Abdel-Latif M.M.M., El-Messery S.M., Al Musayeib N.M., Shehata I.A. "Minutaside A, new a-amylase inhibitor flavonol glucoside from Tagetes minuta: Antidiabetic, antioxidant, and molecular modeling studies" Starch/Stärke, 7, 2015, DOI 10.1002/star.201500068

16- Babar M, Abdel-Latif M.M.M., Murphy A., Ravi N., Byrne P., Kelleher D., Reynolds J. V. Pilot translational study of dietary vitamin C supplementation in Barrett's esophagus. Diseases of the Esophagus. 2010;3:271-276.

17- Baber M, Ennis D, Abdel-Latif M.M., Byrne PJ, Ravi N, Reynolds JV, Differential molecular changes in patients with asymptomatic long-segment Barrett's esophagus treated by anti-reflux surgery or medical therapy. American Journal of Surgery. 2010;199:137-143.

18- Basel A. Abdel-Wahab, Mohamed M. Abdel-Latif, Atef A. Abdel-Hafez. Comparative study for brain delivery of tacrine using polysorbate 80-coated poly(butylcyanoacrylate) and pegylated-poly(butylcyanoacrylate) nanoparticles. International Journal of Nanotechnology and Biomaterials. 2009;2:360-374.

19- Abdel-Wahab B.A., Mahran S. Abd El-Rahman M.S., Abd El-latif M.M. Enhanced Delivery of Baclofen Through Blood-Brain Barrier Using Poly(butyl cyanoacrylate) Nanoparticles Coated with Polysorbate 80 As A Carrying VectoThe International Conference For Nanotechnology Industries King Saud university-Riyadh April 5-7 2009.

20- Abdel-Latif M.M.M., Reynolds J. V, Kelleher D. Inflammation and esophageal carcinogenesis. Curr Opin Pharmacol 2009:9:396-404.

21- Deoxycholate induces COX-2 expression via Erk1/2-, p38-MAPK and AP-1-dependent mechanisms in esophageal cancer cells. Looby E., Abdel-Latif M.M.M., Athié-Morales V., Duggan S., Aideen Long A., Kelleher D. BMC Cancer 2009;9:190.

22- Abdel-Latif M.M.M., Windle H., Davies A., Volkov Y., Kelleher D. A new mechanism of gastric epithelial injury induced by acid exposure: the role of Egr-1 and ERK signaling pathways. J Cell Biochem 2009; 108:249-260.

23- Abdel-Latif M.M., Kelleher D., Reynolds J. V. Potential role of nuclear factor-kappaB in oesophageal carcinogenesis. Journal of Surgical Research 2009;153:172-80.

24- Shah S. A., Volkov Y., Arfin Q., Abdel-Latif M.M., Kelleher D. Ursodeoxycholic Acid Inhibits Interleukin beta 1 and Deoxycholic Acid-

12

http://www.researchgate.net/publication/263812324_Knowledge_and_Awareness_of_Adverse_Drug_Reactions_and_Pharmacovigilance_Practices_among_Healthcare_Professionals_in_Al-Madinah_Al-Munawwarah_Kingdom_of_Saudi_Arabia



http://www.researchgate.net/publication/270912956_Molecular_mechanisms_of_constitutive_and_inducible_NF-kappaB_activation_in_oesophageal_adenocarcinoma



http://www.researchgate.net/researcher/38205116_Dermot_Kelleher

http://www.researchgate.net/researcher/58553760_Basel_A_Abdel-Wahab


Induced Activation of NF-kappa B and AP-1 in Human Colon Cancer Cells. International Journal of Cancer 2006;118:532-539.

25- Duggan S., Abdel-Latif M.M., Fox E., Gallaher W., Reynolds J. V., Kelleher D. Low pH Results in Co-ordinate Regulation of Gene Expression in Oesophageal Cells. Carcinogenesis. 2006;27: 319-327.

26- Mohamed M. M. Abdel-Latif, Windle H. J., Terres A. M., Ní Eidhin D., Kelleher D., Reynolds J. V.. Helicobacter pylori Extract Induces Nuclear Factor-kappa B, Activator Protein-1 and Cyclooxygenase-2 in Esophageal Epithelial Cells. Journal of Gastrointestinal Surgery 2006;10:551-62.

27- Abdel-Latif M.M., El-Homasany B. S., Windle H. J., Sabra K., Kelleher D. Caffeic Acid Phenethyl Ester Modulates Helicobacter pylori Induced Nuclear Factor-kappa B and Activator Protein-1 Expression in Gastric Cancer Cells. British Journal of Pharmacology 2005;146:1139-1147.

28- Abdel-Latif M.M., Raouf A. A., Sabra K., Kelleher D., Reynolds J. V. Vitamin C Enhances Chemosensitization of Esophageal Cancer Cells in Vitro. Journal of Chemotherapy 2005;17: 539-549.

29- Abdel-Latif M.M., O’ Riordan J. M., Ravi N., Kelleher D., Reynolds J. V. Activated Nuclear Factor-kappa B and Cytokine Profiles in the Esophagus Parallel Tumor Regression Following Neoadjuvant Chemoradiotherpy. Diseases of the Esophagus 2005;18:246-252.

30- O’Riordan J., Abdel-Latif M.M., Byrne P., Reynolds J. V. Pro-inflammatory cytokine and nuclear factor kappa B expression along the inflammation- metaplasia- dysplasia- adenocarcinoma sequence in the oesophagus. American Journal of Gastroenterology 2005;100:1-8.

31- O' Toole D., Abdel-Latif M.M., Long A., Windle H. J., Murphy A. M., Bowie A., O' Neill L. A. J., Weir D. G., Kelleher D. Low pH and Helicobacter pylori Increase Nuclear Factor Kappa B Binding in Gastric Epithelial Cells: A common pathway for epithelial cell injury? Journal of Cellular Biochemistry 2005;96:589-598.

32- Abdel-Latif M.M., O’Riordan J., Windle H. J., Carton E., Kelleher D., Reynolds J. V. Evaluation of Nuclear Factor-kappa B (NF-B) activation in Barrett’s tumorigenesis and response of esophageal adenocarcinoma to neoadjuvant therapy. Annals of Surgery 2004; 239:491-500.

33- Abdel-Latif M.M., Windle H. J., Nì Eidhin D., Sabra K., Kelleher D. Helicobacter pylori Induces the Early Growth Response-1 Gene in Gastric Epithelial Cells. Infection and Immunity 2004;72: 3549-3560.

34- Ashraf K. Al-Hussani, Abdel-Rahim El-Shanawany, Enas A. Daef, Mohamed M. Abdel-Latif. Topical Clotrimazole Versus Topical Miconazole Nitrate in the Treatment of Experimental Keratomycosis. Bulletin of Ophthalmology Society of Egypt 1997;90: 809-812.

35- Ashraf K. Al-Hussaini, El-Said A. Ibrahim, Abdel-Rahim El-Shanawany, Mohamed M. Abdel-Latif, Tarek A. Ali. Topical Clotrimazole for the Treatment of Fungal Keratitis in Humans. Bulletin of Ophthalmology Society of Egypt 1997;90: 813-815.

36- S. A. Ibrahim, S. S. Tous, A. K. Al-Hussani, A. A. El-Shanawany, E. A. Daef, A. S. Aly, Mohamed M Abdel-Latif. 16th Pharmaceutical Technology Conference, Athens, Greece, March (1997).

13

· web viewhelicobacter pylori induces the early growth response-1 gene in gastric epithelial...

Documents